Exploring how cholangiocytes can help regenerate the liver

Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration

NIH-funded research Boston Medical Center · NIH-11085110

This study is looking at how special cells in the bile ducts can help the liver heal itself when it’s not working well, which could lead to new treatments for people with serious liver problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Medical Center NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11085110 on NIH RePORTER

What this research studies

This research investigates the role of cholangiocytes, a type of cell in the bile ducts, in promoting liver regeneration, particularly when traditional liver cell regeneration is impaired. The study aims to understand how these cells can transition into liver progenitor cells and eventually become functional liver cells, which could provide a new therapeutic approach for patients with end-stage liver disease. By using animal models, including zebrafish, the researchers will identify pathways that can be targeted to enhance this regenerative process. The ultimate goal is to develop treatments that can improve liver function in patients suffering from severe liver conditions.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals suffering from end-stage liver disease or acute liver injury.

Not a fit: Patients with liver diseases that do not involve cholangiocyte dysfunction may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that enhance liver regeneration, potentially reducing the need for liver transplants.

How similar studies have performed: Previous studies have shown promising results in using cholangiocyte-driven regeneration in animal models, indicating potential for success in human applications.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions acute liver injury
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.